Last update: Nov. 5, 2014
Not risky for breastfeeding or infant.
Excreted into breast milk in non-significant amount without harm effects observed among breastfed infants of mothers treated with Tobramycin.
In addition, a low oral bioavailability renders concentration in the infant's plasma be nil or low.
Be aware of false negative results that may be obtained from infants with bacterial cultures when the mother is on antibiotics and higher risk of acute diarrhea by alteration of normal gut flora.
When used in eye drops, because of a low dose and topical application with minimal absorption in the serum, it is compatible while breastfeeding.
We do not have alternatives for Tobramycin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM